Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients.

Blom LJ, Visser M, Christiaans I, Scholten MF, Bootsma M, van den Berg MP, Yap SC, van der Heijden JF, Doevendans PA, Loh P, Postema PG, Barge-Schaapsveld DQ, Hofman N, Volders PGA, Wilde AA, Hassink RJ.

Europace. 2019 Oct 1;21(10):1519-1526. doi: 10.1093/europace/euz151.

PMID:
31114860
2.

Determination and Interpretation of the QT Interval.

Vink AS, Neumann B, Lieve KVV, Sinner MF, Hofman N, El Kadi S, Schoenmaker MHA, Slaghekke HMJ, de Jong JSSG, Clur SB, Blom NA, Kääb S, Wilde AAM, Postema PG.

Circulation. 2018 Nov 20;138(21):2345-2358. doi: 10.1161/CIRCULATIONAHA.118.033943.

PMID:
30571576
3.

Effect of Age and Sex on the QTc Interval in Children and Adolescents With Type 1 and 2 Long-QT Syndrome.

Vink AS, Clur SB, Geskus RB, Blank AC, De Kezel CC, Yoshinaga M, Hofman N, Wilde AA, Blom NA.

Circ Arrhythm Electrophysiol. 2017 Apr;10(4). pii: e004645. doi: 10.1161/CIRCEP.116.004645.

PMID:
28356306
4.

Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation.

Lieve KV, Verkerk AO, Podliesna S, van der Werf C, Tanck MW, Hofman N, van Bergen PF, Beekman L, Bezzina CR, Wilde AAM, Lodder EM.

Int J Cardiol. 2017 Jun 1;236:187-193. doi: 10.1016/j.ijcard.2017.01.113. Epub 2017 Jan 29.

5.

Wingate Test as a Strong Predictor of 1500-m Performance in Elite Speed Skaters.

Hofman N, Orie J, Hoozemans MJM, Foster C, de Koning JJ.

Int J Sports Physiol Perform. 2017 Nov 1;12(10):1288-1292. doi: 10.1123/ijspp.2016-0427. Epub 2017 Dec 19.

PMID:
28253027
6.

Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.

Wilde AA, Moss AJ, Kaufman ES, Shimizu W, Peterson DR, Benhorin J, Lopes C, Towbin JA, Spazzolini C, Crotti L, Zareba W, Goldenberg I, Kanters JK, Robinson JL, Qi M, Hofman N, Tester DJ, Bezzina CR, Alders M, Aiba T, Kamakura S, Miyamoto Y, Andrews ML, McNitt S, Polonsky B, Schwartz PJ, Ackerman MJ.

Circulation. 2016 Sep 20;134(12):872-82. doi: 10.1161/CIRCULATIONAHA.116.021823. Epub 2016 Aug 26.

7.

Role of Genetic Testing in Patients with Ventricular Arrhythmias in Apparently Normal Hearts.

Hofman N, Wilde AA.

Card Electrophysiol Clin. 2016 Sep;8(3):515-23. doi: 10.1016/j.ccep.2016.04.002. Epub 2016 Jun 9. Review.

PMID:
27521086
8.

What's the meaning of local? Using molecular markers to define seed transfer zones for ecological restoration in Norway.

Jørgensen MH, Elameen A, Hofman N, Klemsdal S, Malaval S, Fjellheim S.

Evol Appl. 2016 Apr 6;9(5):673-84. doi: 10.1111/eva.12378. eCollection 2016 Jun.

9.

Asymmetry of parental origin in long QT syndrome: preferential maternal transmission of KCNQ1 variants linked to channel dysfunction.

Itoh H, Berthet M, Fressart V, Denjoy I, Maugenre S, Klug D, Mizusawa Y, Makiyama T, Hofman N, Stallmeyer B, Zumhagen S, Shimizu W, Wilde AA, Schulze-Bahr E, Horie M, Tezenas du Montcel S, Guicheney P.

Eur J Hum Genet. 2016 Aug;24(8):1160-6. doi: 10.1038/ejhg.2015.257. Epub 2015 Dec 16.

10.

Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.

Kolder ICRM, Tanck MWT, Postema PG, Barc J, Sinner MF, Zumhagen S, Husemann A, Stallmeyer B, Koopmann TT, Hofman N, Pfeufer A, Lichtner P, Meitinger T, Beckmann BM, Myerburg RJ, Bishopric NH, Roden DM, Kääb S, Wilde AAM, Schott JJ, Schulze-Bahr E, Bezzina CR.

Circ Cardiovasc Genet. 2015 Jun;8(3):447-456. doi: 10.1161/CIRCGENETICS.114.000785. Epub 2015 Mar 3.

11.

An experience sampling study of PTSD and alcohol-related problems.

Gaher RM, Simons JS, Hahn AM, Hofman NL, Hansen J, Buchkoski J.

Psychol Addict Behav. 2014 Dec;28(4):1013-25. doi: 10.1037/a0037257. Epub 2014 Aug 18.

12.

Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization.

Arking DE, Pulit SL, Crotti L, van der Harst P, Munroe PB, Koopmann TT, Sotoodehnia N, Rossin EJ, Morley M, Wang X, Johnson AD, Lundby A, Gudbjartsson DF, Noseworthy PA, Eijgelsheim M, Bradford Y, Tarasov KV, Dörr M, Müller-Nurasyid M, Lahtinen AM, Nolte IM, Smith AV, Bis JC, Isaacs A, Newhouse SJ, Evans DS, Post WS, Waggott D, Lyytikäinen LP, Hicks AA, Eisele L, Ellinghaus D, Hayward C, Navarro P, Ulivi S, Tanaka T, Tester DJ, Chatel S, Gustafsson S, Kumari M, Morris RW, Naluai ÅT, Padmanabhan S, Kluttig A, Strohmer B, Panayiotou AG, Torres M, Knoflach M, Hubacek JA, Slowikowski K, Raychaudhuri S, Kumar RD, Harris TB, Launer LJ, Shuldiner AR, Alonso A, Bader JS, Ehret G, Huang H, Kao WH, Strait JB, Macfarlane PW, Brown M, Caulfield MJ, Samani NJ, Kronenberg F, Willeit J; CARe Consortium; COGENT Consortium, Smith JG, Greiser KH, Meyer Zu Schwabedissen H, Werdan K, Carella M, Zelante L, Heckbert SR, Psaty BM, Rotter JI, Kolcic I, Polašek O, Wright AF, Griffin M, Daly MJ; DCCT/EDIC, Arnar DO, Hólm H, Thorsteinsdottir U; eMERGE Consortium, Denny JC, Roden DM, Zuvich RL, Emilsson V, Plump AS, Larson MG, O'Donnell CJ, Yin X, Bobbo M, D'Adamo AP, Iorio A, Sinagra G, Carracedo A, Cummings SR, Nalls MA, Jula A, Kontula KK, Marjamaa A, Oikarinen L, Perola M, Porthan K, Erbel R, Hoffmann P, Jöckel KH, Kälsch H, Nöthen MM; HRGEN Consortium, den Hoed M, Loos RJ, Thelle DS, Gieger C, Meitinger T, Perz S, Peters A, Prucha H, Sinner MF, Waldenberger M, de Boer RA, Franke L, van der Vleuten PA, Beckmann BM, Martens E, Bardai A, Hofman N, Wilde AA, Behr ER, Dalageorgou C, Giudicessi JR, Medeiros-Domingo A, Barc J, Kyndt F, Probst V, Ghidoni A, Insolia R, Hamilton RM, Scherer SW, Brandimarto J, Margulies K, Moravec CE, del Greco M F, Fuchsberger C, O'Connell JR, Lee WK, Watt GC, Campbell H, Wild SH, El Mokhtari NE, Frey N, Asselbergs FW, Mateo Leach I, Navis G, van den Berg MP, van Veldhuisen DJ, Kellis M, Krijthe BP, Franco OH, Hofman A, Kors JA, Uitterlinden AG, Witteman JC, Kedenko L, Lamina C, Oostra BA, Abecasis GR, Lakatta EG, Mulas A, Orrú M, Schlessinger D, Uda M, Markus MR, Völker U, Snieder H, Spector TD, Ärnlöv J, Lind L, Sundström J, Syvänen AC, Kivimaki M, Kähönen M, Mononen N, Raitakari OT, Viikari JS, Adamkova V, Kiechl S, Brion M, Nicolaides AN, Paulweber B, Haerting J, Dominiczak AF, Nyberg F, Whincup PH, Hingorani AD, Schott JJ, Bezzina CR, Ingelsson E, Ferrucci L, Gasparini P, Wilson JF, Rudan I, Franke A, Mühleisen TW, Pramstaller PP, Lehtimäki TJ, Paterson AD, Parsa A, Liu Y, van Duijn CM, Siscovick DS, Gudnason V, Jamshidi Y, Salomaa V, Felix SB, Sanna S, Ritchie MD, Stricker BH, Stefansson K, Boyer LA, Cappola TP, Olsen JV, Lage K, Schwartz PJ, Kääb S, Chakravarti A, Ackerman MJ, Pfeufer A, de Bakker PI, Newton-Cheh C.

Nat Genet. 2014 Aug;46(8):826-36. doi: 10.1038/ng.3014. Epub 2014 Jun 22.

13.

Low rate of cardiac events in first-degree relatives of diagnosis-negative young sudden unexplained death syndrome victims during follow-up.

van der Werf C, Stiekema L, Tan HL, Hofman N, Alders M, van der Wal AC, van Langen IM, Wilde AA.

Heart Rhythm. 2014 Oct;11(10):1728-32. doi: 10.1016/j.hrthm.2014.05.028. Epub 2014 May 29.

PMID:
24882506
14.

Thirty-eight years of training distribution in Olympic speed skaters.

Orie J, Hofman N, de Koning JJ, Foster C.

Int J Sports Physiol Perform. 2014 Jan;9(1):93-9. doi: 10.1123/IJSPP.2013-0427.

PMID:
24408352
15.

Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years' experience.

Hofman N, Tan HL, Alders M, Kolder I, de Haij S, Mannens MM, Lombardi MP, Dit Deprez RH, van Langen I, Wilde AA.

Circulation. 2013 Oct 1;128(14):1513-21. doi: 10.1161/CIRCULATIONAHA.112.000091. Epub 2013 Aug 20.

PMID:
23963746
16.

Targeted sequence capture and GS-FLX Titanium sequencing of 23 hypertrophic and dilated cardiomyopathy genes: implementation into diagnostics.

Mook OR, Haagmans MA, Soucy JF, van de Meerakker JB, Baas F, Jakobs ME, Hofman N, Christiaans I, Lekanne Deprez RH, Mannens MM.

J Med Genet. 2013 Sep;50(9):614-26. doi: 10.1136/jmedgenet-2012-101231. Epub 2013 Jun 19.

17.

Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.

van der Werf C, Nederend I, Hofman N, van Geloven N, Ebink C, Frohn-Mulder IM, Alings AM, Bosker HA, Bracke FA, van den Heuvel F, Waalewijn RA, Bikker H, van Tintelen JP, Bhuiyan ZA, van den Berg MP, Wilde AA.

Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):748-56. doi: 10.1161/CIRCEP.112.970517. Epub 2012 Jul 10.

PMID:
22787013
18.

Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to β-blocker therapy in type 1 long-QT syndrome.

Barsheshet A, Goldenberg I, O-Uchi J, Moss AJ, Jons C, Shimizu W, Wilde AA, McNitt S, Peterson DR, Zareba W, Robinson JL, Ackerman MJ, Cypress M, Gray DA, Hofman N, Kanters JK, Kaufman ES, Platonov PG, Qi M, Towbin JA, Vincent GM, Lopes CM.

Circulation. 2012 Apr 24;125(16):1988-96. doi: 10.1161/CIRCULATIONAHA.111.048041. Epub 2012 Mar 28.

19.

Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner.

Amin AS, Giudicessi JR, Tijsen AJ, Spanjaart AM, Reckman YJ, Klemens CA, Tanck MW, Kapplinger JD, Hofman N, Sinner MF, Müller M, Wijnen WJ, Tan HL, Bezzina CR, Creemers EE, Wilde AA, Ackerman MJ, Pinto YM.

Eur Heart J. 2012 Mar;33(6):714-23. doi: 10.1093/eurheartj/ehr473. Epub 2011 Dec 23.

20.

[Premature sudden death--consider serious familial heart rhythm disturbances].

Postema PG, Christiaans I, Alders M, Hofman N, Wilde AA.

Ned Tijdschr Geneeskd. 2011;155(39):A3391. Dutch.

PMID:
21961687
21.

Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6.

Postema PG, Christiaans I, Hofman N, Alders M, Koopmann TT, Bezzina CR, Loh P, Zeppenfeld K, Volders PG, Wilde AA.

Neth Heart J. 2011 Jun;19(6):290-6. doi: 10.1007/s12471-011-0102-8.

22.

Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients.

Jons C, O-Uchi J, Moss AJ, Reumann M, Rice JJ, Goldenberg I, Zareba W, Wilde AA, Shimizu W, Kanters JK, McNitt S, Hofman N, Robinson JL, Lopes CM.

Sci Transl Med. 2011 Mar 30;3(76):76ra28. doi: 10.1126/scitranslmed.3001551.

23.

Recurrent and Founder Mutations in the Netherlands: the Long-QT Syndrome.

Hofman N, Jongbloed R, Postema PG, Nannenberg E, Alders M, Wilde AA.

Neth Heart J. 2011 Jan;19(1):10-16. Epub 2010 Dec 17.

24.

Sodium channelopathies: do we really understand what's going on?

Postema PG, Mosterd A, Hofman N, Alders M, Wilde AA.

J Cardiovasc Electrophysiol. 2011 May;22(5):590-3. doi: 10.1111/j.1540-8167.2010.01892.x. Epub 2010 Aug 31.

PMID:
20812931
25.

Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands.

van der Werf C, Hofman N, Tan HL, van Dessel PF, Alders M, van der Wal AC, van Langen IM, Wilde AA.

Heart Rhythm. 2010 Oct;7(10):1383-9. doi: 10.1016/j.hrthm.2010.05.036. Epub 2010 May 31.

PMID:
20646679
26.

Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment?

Hofman N, Tan HL, Alders M, van Langen IM, Wilde AA.

J Am Coll Cardiol. 2010 Jun 8;55(23):2570-6. doi: 10.1016/j.jacc.2009.12.063.

27.

Genetic basis of malignant channelopathies and ventricular fibrillation in the structurally normal heart.

Hofman N, van Lochem LT, Wilde AA.

Future Cardiol. 2010 May;6(3):395-408. doi: 10.2217/fca.10.11. Review.

PMID:
20462344
28.

Genetic testing in cardiovascular diseases.

Hofman N, van Langen I, Wilde AA.

Curr Opin Cardiol. 2010 May;25(3):243-8. doi: 10.1097/HCO.0b013e3283374d69. Review.

PMID:
20164764
29.

The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long QT syndrome.

Clur SA, Chockalingam P, Filippini LH, Widyanti AP, Van Cruijsen M, Blom NA, Alders M, Hofman N, Wilde AA.

Pediatr Cardiol. 2010 May;31(4):462-8. doi: 10.1007/s00246-009-9603-2. Epub 2009 Dec 3.

30.

Founder mutations in the Netherlands: SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best characterised families worldwide.

Postema PG, Van den Berg M, Van Tintelen JP, Van den Heuvel F, Grundeken M, Hofman N, Van der Roest WP, Nannenberg EA, Krapels IP, Bezzina CR, Wilde A.

Neth Heart J. 2009 Nov;17(11):422-8.

31.

The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.

Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, Mannens MM, Wilde AA, Ackerman MJ.

J Am Coll Cardiol. 2009 Nov 24;54(22):2065-74. doi: 10.1016/j.jacc.2009.08.022.

32.

Genotype-phenotype aspects of type 2 long QT syndrome.

Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, January CT, Tester DJ, Zareba W, Robinson JL, Qi M, Vincent GM, Kaufman ES, Hofman N, Noda T, Kamakura S, Miyamoto Y, Shah S, Amin V, Goldenberg I, Andrews ML, McNitt S.

J Am Coll Cardiol. 2009 Nov 24;54(22):2052-62. doi: 10.1016/j.jacc.2009.08.028.

33.

Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy.

Johnson JN, Hofman N, Haglund CM, Cascino GD, Wilde AA, Ackerman MJ.

Neurology. 2009 Jan 20;72(3):224-31. doi: 10.1212/01.wnl.0000335760.02995.ca. Epub 2008 Nov 26.

34.

Phenotypic variability in Caucasian and Japanese patients with matched LQT1 mutations.

Liu JF, Goldenberg I, Moss AJ, Shimizu W, Wilde AA, Hofman N, McNitt S, Zareba W, Miyamato Y, Robinson JL, Andrews ML.

Ann Noninvasive Electrocardiol. 2008 Jul;13(3):234-41. doi: 10.1111/j.1542-474X.2008.00226.x.

35.

Cardiogenetic counselling in a non-university hospital.

Kodde J, Hofman N, Reichert CL, van Langen IM, Wilde AA.

Neth Heart J. 2007 Dec;15(12):412-4.

36.

Contribution of inherited heart disease to sudden cardiac death in childhood.

Hofman N, Tan HL, Clur SA, Alders M, van Langen IM, Wilde AA.

Pediatrics. 2007 Oct;120(4):e967-73.

PMID:
17908752
37.

Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system?

Hofman N, Wilde AA, Tan HL.

Eur Heart J. 2007 Jun;28(11):1399. Epub 2007 May 5. No abstract available.

PMID:
17483524
38.

Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.

Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL, Qi M, Vincent GM, Ackerman MJ, Kaufman ES, Hofman N, Seth R, Kamakura S, Miyamoto Y, Goldenberg I, Andrews ML, McNitt S.

Circulation. 2007 May 15;115(19):2481-9. Epub 2007 Apr 30.

39.

[Genetic identification of patients and families with a long-QT syndrome: large regional differences in the result of 10 years].

Hofman N, Postema PG, van Langen IM, Nannenberg EA, Alders M, Jongbloed R, Smeets HJ, Wilde AA.

Ned Tijdschr Geneeskd. 2007 Mar 17;151(11):644-8. Dutch.

PMID:
17441570
40.

Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system?

Hofman N, Wilde AA, Kääb S, van Langen IM, Tanck MW, Mannens MM, Hinterseer M, Beckmann BM, Tan HL.

Eur Heart J. 2007 Mar;28(5):575-80. Epub 2006 Nov 7.

PMID:
17090615
41.

Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome.

Meregalli PG, Ruijter JM, Hofman N, Bezzina CR, Wilde AA, Tan HL.

J Cardiovasc Electrophysiol. 2006 Aug;17(8):857-64. Epub 2006 Jun 9.

PMID:
16764707
42.

Case report of a posterior disc displacement without and with reduction.

Huddleston Slater JJ, Lobbezoo F, Hofman N, Naeije M.

J Orofac Pain. 2005 Fall;19(4):337-42.

PMID:
16279486
43.

Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey.

van Langen IM, Birnie E, Schuurman E, Tan HL, Hofman N, Bonsel GJ, Wilde AA.

Clin Genet. 2005 Oct;68(4):360-8.

PMID:
16143023
44.

Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives.

Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA.

Circulation. 2005 Jul 12;112(2):207-13. Epub 2005 Jul 5.

PMID:
15998675
45.

Is temporomandibular pain in chronic whiplash-associated disorders part of a more widespread pain syndrome?

Visscher C, Hofman N, Mes C, Lousberg R, Naeije M.

Clin J Pain. 2005 Jul-Aug;21(4):353-7.

PMID:
15951654
46.

Toward critical research ethics: transforming ethical conduct in qualitative health care research.

Hofman NG.

Health Care Women Int. 2004 Aug;25(7):647-62. Review.

PMID:
15487483
47.

Family and population strategies for screening and counselling of inherited cardiac arrhythmias.

van Langen IM, Hofman N, Tan HL, Wilde AA.

Ann Med. 2004;36 Suppl 1:116-24.

PMID:
15176433
48.
49.

Biomechanics of the human temporomandibular joint during chewing.

Naeije M, Hofman N.

J Dent Res. 2003 Jul;82(7):528-31.

PMID:
12821713
50.

Management of the non-descended testis: doubtful value of luteinizing-hormone-releasing-hormone (LHRH). A double-blind, placebo-controlled multicentre study.

Olsen LH, Genster HG, Mosegaard A, Jørgensen FS, Hofman N, Jensen VB, Lassen LB, Rassmussen M, Vinzents L, Dammegaard L, et al.

Int J Androl. 1992 Apr;15(2):135-43.

PMID:
1349301

Supplemental Content

Loading ...
Support Center